Current diagnostic and therapeutic strategies for COVID-19

Binbin Chen; Mengli Liu; Chengzhi Huang

Journal of Pharmaceutical Analysis (Apr 2021)

Current diagnostic and therapeutic strategies for COVID-19

Binbin Chen,
Mengli Liu,
Chengzhi Huang

Affiliations

Binbin Chen: College of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China; School of Chemistry & Molecular Engineering, East China University of Science and Technology, Shanghai, 200237, China
Mengli Liu: College of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China
Chengzhi Huang: Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, Southwest University, Chongqing, 400715, China; Key Laboratory of Luminescence and Real-Time Analytical System, Chongqing Science and Technology Bureau, College of Pharmaceutical Science, Southwest University, Chongqing, 400715, China; Corresponding author.

Journal volume & issue: Vol. 11, no. 2
pp. 129 – 137

Abstract

Read online

The outbreak and spread of novel coronavirus disease 2019 (COVID-19) with pandemic features, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have greatly threatened global public health. Given the perniciousness of COVID-19 pandemic, acquiring a deeper understanding of this viral illness is critical for the development of new vaccines and therapeutic options. In this review, we introduce the systematic evolution of coronaviruses and the structural characteristics of SARS-CoV-2. We also summarize the current diagnostic tools and therapeutic strategies for COVID-19.

Published in Journal of Pharmaceutical Analysis

ISSN: 2095-1779 (Print); 2214-0883 (Online)
Publisher: Elsevier
Country of publisher: China
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://www.journals.elsevier.com/journal-of-pharmaceutical-analysis/

About the journal

Abstract

Keywords